The label-free array systems market size has grown strongly in recent years. It will grow from $1.48 billion in 2025 to $1.59 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to limited availability of label-free platforms, reliance on traditional labeling methods, growing pharmaceutical R&D, expansion of academic and research institutes, adoption of conventional biosensors.
The label-free array systems market size is expected to see strong growth in the next few years. It will grow to $2.1 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to advancements in surface plasmon resonance and bio-layer interferometry, increasing contract research organizations (CROs) adoption, rising demand for high-throughput and automated systems, growing focus on kinetics and affinity mapping, integration with AI and big data analytics. Major trends in the forecast period include rising adoption of label-free detection technologies, increasing demand for real-time molecular interaction analysis, integration of high-throughput screening capabilities, growing use in drug discovery and protein-protein interaction studies, enhanced focus on sensitivity and accuracy of assays.
The rising risk of lifestyle-related chronic diseases is expected to drive the growth of the label-free array systems market in the coming years. These chronic conditions, primarily caused by unhealthy behaviors such as poor diet, physical inactivity, smoking, and excessive alcohol consumption, are becoming increasingly prevalent due to more sedentary lifestyles. Desk-bound occupations and screen-based leisure activities contribute to reduced physical activity and adverse metabolic health outcomes. Label-free array systems are advanced biosensing technologies that enable real-time, high-throughput detection of biomolecular interactions without the need for fluorescent or radioactive labels. These systems are increasingly important in mitigating lifestyle-related chronic diseases by facilitating early detection, risk evaluation, and personalized prevention strategies. For example, in May 2025, the World Health Organization, a Switzerland-based intergovernmental organization, reported that around 2.5 billion adults aged 18 and over were overweight in 2022, with over 890 million classified as obese. The report also projected that by 2032, nearly 35 million children under the age of five would be affected by overweight conditions. Thus, the growing threat of lifestyle-related chronic diseases is expected to propel the label-free array systems market forward.
Leading companies in the label-free array systems market are prioritizing the development of advanced technologies, such as label-free biosensors, to streamline the testing process. Label-free biosensors are analytical tools that detect biological interactions directly, without the use of fluorescent or radioactive markers. For example, in February 2024, SPOC Proteomics Inc., a US-based life sciences company, introduced customizable SPOC protein biosensor chips. These chips enable real-time, label-free detection for up to 1,000 fully folded proteins on a compact 1.5 cm² SPR chip. The technology employs a novel method that synthesizes proteins directly from DNA in nanoliter-sized wells while simultaneously capturing and purifying them on the sensor surface. This eliminates the need for conventional recombinant protein production, reducing costs by 10 to 100 times compared to traditional techniques. Additionally, SPOC protein biosensor chips provide large-scale qualitative, quantitative, and kinetic data, making them highly suitable for high-throughput proteomic research.
In January 2023, Charles River Laboratories International Inc., a US-based biotechnology company, acquired SAMDI Tech Inc. for $50 million. This acquisition enhances Charles River’s drug discovery capabilities by integrating its scientific expertise with SAMDI Tech’s mass spectrometry-based, label-free screening technology. SAMDI Tech Inc. is a US-based producer of label-free array systems.
Major companies operating in the label-free array systems market are Merck KGaA, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Cytiva, PerkinElmer Inc, Sartorius AG, Bruker Corporation, Horiba Instruments Incorporated, Malvern Panalytical Ltd, Reichert Inc, Attana AB, NanoSPR Devices, BioNavis Ltd, Biosensing Instrument Inc, GeSiM Co, Plexera LLC, Plasmetrix, Nicoya Lifesciences Inc, Creoptix AG, Sierra Sensors GmbH.
North America was the largest region in the label-free array systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the label-free array systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the label-free array systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the label-free array systems market by increasing the cost of imported equipment, sensor chips, and reagents, particularly impacting segments such as SPR and BLI systems. Regions like Asia-Pacific, including China and India, face higher import duties, leading to elevated production and operational costs. While tariffs create supply chain challenges and slower adoption rates, they also encourage local manufacturing, innovation in sensor and platform technologies, and increased investment in domestic production capabilities.
The label-free array systems market research report is one of a series of new reports that provides label-free array systems market statistics, including label-free array systems industry global market size, regional shares, competitors with a label-free array systems market share, detailed label-free array systems market segments, market trends and opportunities, and any further data you may need to thrive in the label-free array systems industry. This label-free array systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Label-free array systems are analytical platforms that detect and quantify molecular interactions without requiring chemical or fluorescent labels. These systems operate by monitoring changes in physical properties such as mass, refractive index, or electrical impedance to detect the presence or behavior of biomolecules.
The primary technologies used in label-free array systems include surface plasmon resonance, biolayer interferometry, cellular dielectric spectroscopy, among others. Surface plasmon resonance (SPR) is an optical detection technique that measures real-time biomolecular interactions without labels. It utilizes various components such as sensor chips, reagents, consumables, and others, and is employed in applications like drug discovery, protein-protein interaction studies, receptor-ligand assays, thermodynamics, kinetics, and affinity mapping. The technology is used by a range of end-users including pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations, and more.
The label-free array systems market consists of revenues earned by entities by providing services such as custom assay development, contract research services, surface chemistry consulting, and method validation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The label-free array systems market also includes sales of microarray slides, detection instruments, and sample preparation kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The label-free array systems market size is expected to see strong growth in the next few years. It will grow to $2.1 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to advancements in surface plasmon resonance and bio-layer interferometry, increasing contract research organizations (CROs) adoption, rising demand for high-throughput and automated systems, growing focus on kinetics and affinity mapping, integration with AI and big data analytics. Major trends in the forecast period include rising adoption of label-free detection technologies, increasing demand for real-time molecular interaction analysis, integration of high-throughput screening capabilities, growing use in drug discovery and protein-protein interaction studies, enhanced focus on sensitivity and accuracy of assays.
The rising risk of lifestyle-related chronic diseases is expected to drive the growth of the label-free array systems market in the coming years. These chronic conditions, primarily caused by unhealthy behaviors such as poor diet, physical inactivity, smoking, and excessive alcohol consumption, are becoming increasingly prevalent due to more sedentary lifestyles. Desk-bound occupations and screen-based leisure activities contribute to reduced physical activity and adverse metabolic health outcomes. Label-free array systems are advanced biosensing technologies that enable real-time, high-throughput detection of biomolecular interactions without the need for fluorescent or radioactive labels. These systems are increasingly important in mitigating lifestyle-related chronic diseases by facilitating early detection, risk evaluation, and personalized prevention strategies. For example, in May 2025, the World Health Organization, a Switzerland-based intergovernmental organization, reported that around 2.5 billion adults aged 18 and over were overweight in 2022, with over 890 million classified as obese. The report also projected that by 2032, nearly 35 million children under the age of five would be affected by overweight conditions. Thus, the growing threat of lifestyle-related chronic diseases is expected to propel the label-free array systems market forward.
Leading companies in the label-free array systems market are prioritizing the development of advanced technologies, such as label-free biosensors, to streamline the testing process. Label-free biosensors are analytical tools that detect biological interactions directly, without the use of fluorescent or radioactive markers. For example, in February 2024, SPOC Proteomics Inc., a US-based life sciences company, introduced customizable SPOC protein biosensor chips. These chips enable real-time, label-free detection for up to 1,000 fully folded proteins on a compact 1.5 cm² SPR chip. The technology employs a novel method that synthesizes proteins directly from DNA in nanoliter-sized wells while simultaneously capturing and purifying them on the sensor surface. This eliminates the need for conventional recombinant protein production, reducing costs by 10 to 100 times compared to traditional techniques. Additionally, SPOC protein biosensor chips provide large-scale qualitative, quantitative, and kinetic data, making them highly suitable for high-throughput proteomic research.
In January 2023, Charles River Laboratories International Inc., a US-based biotechnology company, acquired SAMDI Tech Inc. for $50 million. This acquisition enhances Charles River’s drug discovery capabilities by integrating its scientific expertise with SAMDI Tech’s mass spectrometry-based, label-free screening technology. SAMDI Tech Inc. is a US-based producer of label-free array systems.
Major companies operating in the label-free array systems market are Merck KGaA, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Cytiva, PerkinElmer Inc, Sartorius AG, Bruker Corporation, Horiba Instruments Incorporated, Malvern Panalytical Ltd, Reichert Inc, Attana AB, NanoSPR Devices, BioNavis Ltd, Biosensing Instrument Inc, GeSiM Co, Plexera LLC, Plasmetrix, Nicoya Lifesciences Inc, Creoptix AG, Sierra Sensors GmbH.
North America was the largest region in the label-free array systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the label-free array systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the label-free array systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the label-free array systems market by increasing the cost of imported equipment, sensor chips, and reagents, particularly impacting segments such as SPR and BLI systems. Regions like Asia-Pacific, including China and India, face higher import duties, leading to elevated production and operational costs. While tariffs create supply chain challenges and slower adoption rates, they also encourage local manufacturing, innovation in sensor and platform technologies, and increased investment in domestic production capabilities.
The label-free array systems market research report is one of a series of new reports that provides label-free array systems market statistics, including label-free array systems industry global market size, regional shares, competitors with a label-free array systems market share, detailed label-free array systems market segments, market trends and opportunities, and any further data you may need to thrive in the label-free array systems industry. This label-free array systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Label-free array systems are analytical platforms that detect and quantify molecular interactions without requiring chemical or fluorescent labels. These systems operate by monitoring changes in physical properties such as mass, refractive index, or electrical impedance to detect the presence or behavior of biomolecules.
The primary technologies used in label-free array systems include surface plasmon resonance, biolayer interferometry, cellular dielectric spectroscopy, among others. Surface plasmon resonance (SPR) is an optical detection technique that measures real-time biomolecular interactions without labels. It utilizes various components such as sensor chips, reagents, consumables, and others, and is employed in applications like drug discovery, protein-protein interaction studies, receptor-ligand assays, thermodynamics, kinetics, and affinity mapping. The technology is used by a range of end-users including pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations, and more.
The label-free array systems market consists of revenues earned by entities by providing services such as custom assay development, contract research services, surface chemistry consulting, and method validation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The label-free array systems market also includes sales of microarray slides, detection instruments, and sample preparation kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Label-Free Array Systems Market Characteristics
3. Label-Free Array Systems Market Supply Chain Analysis
4. Global Label-Free Array Systems Market Trends and Strategies
5. Label-Free Array Systems Market Analysis of End Use Industries
7. Global Label-Free Array Systems Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Label-Free Array Systems Total Addressable Market (TAM) Analysis for the Market
9. Label-Free Array Systems Market Segmentation
10. Label-Free Array Systems Market Regional and Country Analysis
11. Asia-Pacific Label-Free Array Systems Market
12. China Label-Free Array Systems Market
13. India Label-Free Array Systems Market
14. Japan Label-Free Array Systems Market
15. Australia Label-Free Array Systems Market
16. Indonesia Label-Free Array Systems Market
17. South Korea Label-Free Array Systems Market
18. Taiwan Label-Free Array Systems Market
19. South East Asia Label-Free Array Systems Market
20. Western Europe Label-Free Array Systems Market
21. UK Label-Free Array Systems Market
22. Germany Label-Free Array Systems Market
23. France Label-Free Array Systems Market
24. Italy Label-Free Array Systems Market
25. Spain Label-Free Array Systems Market
26. Eastern Europe Label-Free Array Systems Market
27. Russia Label-Free Array Systems Market
28. North America Label-Free Array Systems Market
29. USA Label-Free Array Systems Market
30. Canada Label-Free Array Systems Market
31. South America Label-Free Array Systems Market
32. Brazil Label-Free Array Systems Market
33. Middle East Label-Free Array Systems Market
34. Africa Label-Free Array Systems Market
36. Label-Free Array Systems Market Competitive Landscape and Company Profiles
37. Label-Free Array Systems Market Other Major and Innovative Companies
40. Label-Free Array Systems Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Label-Free Array Systems Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses label-free array systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for label-free array systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The label-free array systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Technology: Surface Plasmon Resonance; Bio Layer Interferometry; Cellular Dielectric Spectroscopy; Other Technologies2) By Accessories: Sensor Chips; Reagents; Consumables; Other Accessories
3) By Application: Drug Discovery; Protein-Protein Interactions; Receptor Ligand Assays; Thermodynamics; Kinetics Or Affinity Mapping; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Other End Users
Subsegments:
1) By Surface Plasmon Resonance: Imaging SPR; SPR Microscopy; Multi-Parametric SPR; Localized SPR2) By Bio Layer Interferometry: Fiber Optic-Based BLI; Plate-Based BLI; High-Throughput BLI Systems
3) By Cellular Dielectric Spectroscopy: Real-Time Impedance-Based Systems; Multi-Well Plate CDS Platforms; Label-Free Cytotoxicity Assays
4) By Other Technologies: Microcantilever-Based Systems; Optical Waveguide Grating Sensors; Quartz Crystal Microbalance (QCM); Field-Effect Transistor (FET)-Based Biosensors
Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc; Agilent Technologies Inc; Cytiva; PerkinElmer Inc; Sartorius AG; Bruker Corporation; Horiba Instruments Incorporated; Malvern Panalytical Ltd; Reichert Inc; Attana AB; NanoSPR Devices; BioNavis Ltd; Biosensing Instrument Inc; GeSiM Co; Plexera LLC; Plasmetrix; Nicoya Lifesciences Inc; Creoptix AG; Sierra Sensors GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Label-Free Array Systems market report include:- Merck KGaA
- Thermo Fisher Scientific Inc
- Agilent Technologies Inc
- Cytiva
- PerkinElmer Inc
- Sartorius AG
- Bruker Corporation
- Horiba Instruments Incorporated
- Malvern Panalytical Ltd
- Reichert Inc
- Attana AB
- NanoSPR Devices
- BioNavis Ltd
- Biosensing Instrument Inc
- GeSiM Co
- Plexera LLC
- Plasmetrix
- Nicoya Lifesciences Inc
- Creoptix AG
- Sierra Sensors GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.59 Billion |
| Forecasted Market Value ( USD | $ 2.1 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
